# STOCKHOLM 1.0
#=GF ID   CoV_peptidase
#=GF AC   PF08715.14
#=GF DE   Coronavirus papain-like peptidase
#=GF PI   Viral_protease;
#=GF AU   Mistry J;0000-0003-2479-5322
#=GF AU   Chuguransky S;0000-0002-0520-0736
#=GF SE   pdb_2fe8
#=GF GA   26.00 26.00;
#=GF TC   49.70 26.30;
#=GF NC   23.30 24.30;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Family
#=GF CL   CL0125
#=GF RN   [1]
#=GF RM   10725411
#=GF RT   Virus-encoded proteinases and proteolytic processing in the
#=GF RT   Nidovirales. 
#=GF RA   Ziebuhr J, Snijder EJ, Gorbalenya AE; 
#=GF RL   J Gen Virol 2000;81:853-879.
#=GF RN   [2]
#=GF RM   16581910
#=GF RT   Severe acute respiratory syndrome coronavirus papain-like
#=GF RT   protease: Structure of a viral deubiquitinating enzyme. 
#=GF RA   Ratia K, Saikatendu KS, Santarsiero BD, Barretto N, Baker SC,
#=GF RA   Stevens RC, Mesecar AD; 
#=GF RL   Proc Natl Acad Sci U S A. 2006;103:5717-5722.
#=GF RN   [3]
#=GF RM   10329692
#=GF RT   A human RNA viral cysteine proteinase that depends upon a unique
#=GF RT   Zn2+-binding finger connecting the two domains of a papain-like
#=GF RT   fold .
#=GF RA   Herold J, Siddell SG, Gorbalenya AE;
#=GF RL   J Biol Chem. 1999;274:14918-14925.
#=GF RN   [4]
#=GF RM   33531496
#=GF RT   Structure of papain-like protease from SARS-CoV-2 and its
#=GF RT   complexes with non-covalent inhibitors.
#=GF RA   Osipiuk J, Azizi SA, Dvorkin S, Endres M, Jedrzejczak R, Jones
#=GF RA   KA, Kang S, Kathayat RS, Kim Y, Lisnyak VG, Maki SL, Nicolaescu
#=GF RA   V, Taylor CA, Tesar C, Zhang YA, Zhou Z, Randall G, Michalska K,
#=GF RA   Snyder SA, Dickinson BC, Joachimiak A;
#=GF RL   Nat Commun. 2021;12:743.
#=GF RN   [5]
#=GF RM   34580920
#=GF RT   Evolution of the SARS-CoV-2 proteome in three dimensions (3D)
#=GF RT   during the first 6  months of the COVID-19 pandemic.
#=GF RA   Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook
#=GF RA   JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie
#=GF RA   L, Venkatachalam T, Arnold S, Alfaro Alvarado LH, Catalfano K,
#=GF RA   Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J,
#=GF RA   Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A,
#=GF RA   Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary
#=GF RA   C, Laporte S, Lenkeit E, Martin K, Orellana M, Ortiz-Alvarez de
#=GF RA   la Campa M, Paredes I, Wheeler B, Rupert A, Sam A, See K, Soto
#=GF RA   Zapata S, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA,
#=GF RA   Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield
#=GF RA   J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD,
#=GF RA   Burley SK;
#=GF RL   Proteins. 2021; [Epub ahead of print]
#=GF DR   INTERPRO; IPR013016;
#=GF DR   SO; 0100021; polypeptide_conserved_region;
#=GF CC   This entry contains coronavirus cysteine endopeptidases that
#=GF CC   belong to MEROPS peptidase family C16 and are required for
#=GF CC   proteolytic processing of the replicase polyprotein. All
#=GF CC   coronaviruses encode between one and two accessory cysteine
#=GF CC   proteinases that recognise and process one or two sites in the
#=GF CC   amino-terminal half of the replicase polyprotein during assembly
#=GF CC   of the viral replication complex. HCoV and TGEV encode two
#=GF CC   accessory proteinases, called coronavirus papain-like proteinase
#=GF CC   1 and 2 (PL1-PRO and PL2-PRO). IBV and SARS encodes only one
#=GF CC   called PL-PRO [1-5]. They also function as deubiquitinating and
#=GF CC   deISG15ylating (interferon-induced gene 15) enzymes, disrupting
#=GF CC   host viral immune response to facilitate viral proliferation and
#=GF CC   replication. Therefore, this is an important target to develop
#=GF CC   antiviral treatments [4]. The peptidase family C16 domain is
#=GF CC   about 260 amino acids in length and structures revealed that it
#=GF CC   adopts a fold similar that of de-ubiquitinating enzymes [2,4].
#=GF CC   Structures from SARS-CoV-2 determined that it consists of thumb,
#=GF CC   palm, and fingers subdomains. The thumb is comprised of six
#=GF CC   alpha-helices and a small beta-hairpin; the fingers subdomain 
#=GF CC   is made of six beta-strands and two alpha-helices and includes a
#=GF CC   zinc binding site, in which the zinc ion is coordinated by four
#=GF CC   cysteine residues. Zinc binding is essential for structural
#=GF CC   integrity and protease activity, with a conformation that varies
#=GF CC   most between different PL-PRO structures. The palm subdomain is
#=GF CC   comprised of six beta-strands and includes the catalytic
#=GF CC   residues Cys-His-Asp, located at the interface between the thumb
#=GF CC   and palm subdomains [4,5].
#=GF SQ   3
#=GS R1AB_CVH22/1599-1905  AC P0C6X1.1
#=GS R1AB_IBVB/1174-1482   AC P0C6Y1.1
#=GS R1AB_SARS/1541-1859   AC P0C6X7.1
R1AB_CVH22/1599-1905             EAKVITIKVTEDGVNVHDVTVTTDKSFEQQVGVIADKDKDLSGAVPSDLNTSELLTKAIDVDWVEFYGFKDAVTFATVDHSAFA.YESAV..........VNGIRVLKTSDNNCWVNAVCIALQYSKPHFISQGLDAAWNKFVLGDVEIFVAFVYYVARLMKGDKGDAEDTLTKLSKYLANEAQVQLEHYSSCVECDAKFKNSVASINSAIV.CASVKRDGVQVGY...CVHGIKYYSRVRSVRGRAIIVSVEQLEPCAQSRLLSGVAYTA..FSGPVDKGH.YTVYDTAKKSMY..DGDRFVKHDLSLLSVTSVVMVGGY....VAPVNT
#=GR R1AB_CVH22/1599-1905  pAS   .................................................................................................................*.......................................................................................................................................................................*...............*.................................
#=GR R1AB_CVH22/1599-1905  sAS   ...............................................................................................................................................................................................................................................................................................*...........................................
R1AB_IBVB/1174-1482              TCKQKTIYLTEDGVKYRSIVLKPGDSLG.QFGQVYAKNKI...VFTADDVEDKEILYVPTTD.......KSILEYYGLDAQKYVIYLQTL..AQKWNVQYRDNFLILEWRDGNCWISSAIVLLQAAKIRFKG.FLTEAWAKLLGGDPTDFVAWCYASCTAKVGDFSDANWLLANLAEHFDADYTNAFLKKRVSCNCGIK.SYELRGLEACIQPVRATNLLHFKTQYSNCPTCGANNTDEVIEASLPYLLLFATDG.PATVDCDEDAVGTVV..FVGSTNSGHCYT..QAAGQAFD..NLAKDRKFGKKSPYITAMYTRFAFKNETSLPVAK
#=GR R1AB_IBVB/1174-1482   AS    .................................................................................................................*.......................................................................................................................................................................*............*....................................
R1AB_SARS/1541-1859              EVKTIKVFTTVDNTNLHTQLVDMSMTYGQQFGPTYLDGADVTKIKPHVNHEGKTFFVLPSDDTLRSEAFE...YYHTLDESFLGRYMSALNHTKKWKFPQVGGLTSIKWADNNCYLSSVLLALQQLEVKFNAPALQEAYYRARAGDAANFCALILAYSNKTVGELGDVRETMTHLLQHANLESAKRVLN.VVCKHCGQK.TTTLTGVEAVMY.MGTLSYDNLKTGVSIPCVCGRDATQYLVQQESSFVMMSA....PPAEYKLQQGTFLCANEYTGNYQCGH.YT.HITAKETLYRIDGAHLTKMSEYKGPVTDVFYKETSYTTTIKPVSY
#=GR R1AB_SARS/1541-1859   AS    .................................................................................................................*.......................................................................................................................................................................*...............*.................................
#=GC seq_cons                    EsKsITIalTEDGVNlHollVcsucSaGQQFGslYsKsKDlotlhPuDssEuKplhhlPosDhlc..uFKshlpYaTLDcStauhYhSAL..spKWph..VsGlplLKWuDNNCWlSSVllALQtuKl+Fpu.uLsEAWsKhluGDsssFVAalYAsustpVGDhGDAc-TLT+LucHhssEussplL+hsVCscCGtK.osoLsGlEAsIh.suolshDslKTGYS.sCVCGtcsTscVlpscusalllSApph.PsAps+LpsGVuhsA..FoGssssGH.YT.apTAKcohY..DGA+hsKaucppssVTuVah+tuahspTltPVup
